TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trandolapril And Verapamil Hydrochloride, and when can generic versions of Trandolapril And Verapamil Hydrochloride launch?
Trandolapril And Verapamil Hydrochloride is a drug marketed by Glenmark Pharms Ltd and is included in one NDA.
The generic ingredient in TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trandolapril And Verapamil Hydrochloride
A generic version of TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE was approved as trandolapril; verapamil hydrochloride by GLENMARK PHARMS LTD on May 5th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE?
- What are the global sales for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE?
- What is Average Wholesale Price for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE?
Summary for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 5 |
| Patent Applications: | 2 |
| What excipients (inactive ingredients) are in TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE? | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE excipients list |
| DailyMed Link: | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Authority, Hong Kong | Phase 4 |
| Assaf-Harofeh Medical Center | |
| Mario Negri Institute for Pharmacological Research | Phase 3 |
See all TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE clinical trials
Pharmacology for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
US Patents and Regulatory Information for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-004 | Aug 30, 2010 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-003 | May 5, 2010 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-001 | May 26, 2010 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-002 | May 26, 2010 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
